Correction Cite This: ACS Med. Chem. Lett. XXXX, XXX, XXX-XXX
pubs.acs.org/acsmedchemlett
Correction to “Structure Based Design of Non-Natural Peptidic Macrocyclic Mcl‑1 Inhibitors” Jeffrey W. Johannes,* Stephanie Bates, Carl Beigie, Matthew A. Belmonte, John Breen, Shenggen Cao, Paolo A. Centrella, Matthew A. Clark, John W. Cuozzo, Christoph E. Dumelin, Andrew D. Ferguson, Sevan Habeshian, David Hargreaves, Camil Joubran, Steven Kazmirski, Anthony D. Keefe, Michelle L. Lamb, Haiye Lan, Yunxia Li, Hao Ma, Scott Mlynarski, Martin J. Packer, Philip B. Rawlins, Daniel W. Robbins, Haidong Shen, Eric A. Sigel, Holly H. Soutter, Nancy Su, Dawn M. Troast, Haiyun Wang, Kate F. Wickson, Chengyan Wu, Ying Zhang, Qiuying Zhao, Xiaolan Zheng, and Alexander W. Hird ACS Med. Chem. Lett. 2017, 8, 239−244. DOI: 10.1021/acsmedchemlett.6b00464 In our recent paper “Structure Based Design of Non-Natural Peptidic Macrocyclic Mcl-1 Inhibitors” (DOI: 10.1021/ acsmedchemlett.6b00464), there is a typographical error in the main text. Table 1A, compound 10, should read R5 = Me and Mcl-1 FRET IC50 = 2.25.
© XXXX American Chemical Society
A
DOI: 10.1021/acsmedchemlett.7b00397 ACS Med. Chem. Lett. XXXX, XXX, XXX−XXX
